A Study to Assess the Safety and Tolerability Profile of TR399 in Healthy Volunteers and Erectile Dysfunction Patients

NCT03102398 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Erectile Dysfunction

Interventions

DRUG: TR-399 (5% Vardenafil HCl·3H2O, topical gel)

Sponsor

Tritech Biopharmaceuticals Co., Ltd.

Collaborators

[object Object]